| CTRI Number |
CTRI/2025/10/096166 [Registered on: 16/10/2025] Trial Registered Prospectively |
| Last Modified On: |
16/10/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Process of Care Changes |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Use of Silodosin in preventing post-operative urinary retention after spine surgeries |
|
Scientific Title of Study
|
Efficacy Of Oral Silodosin During Peri-Operative Period In Preventing Post-Operative Urinary Retention (POUR) In Spine Surgeries - A Randomised Controlled Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Vidyadhara Srinivasa |
| Designation |
Chairman and HOD, Spine Surgery |
| Affiliation |
Manipal Hospital, Old Airport Road, Bangalore |
| Address |
Room no. 1, Manipal Comprehensive Spine Care Centre, No. 98, Rustumbagh, Manipal Hospital, Old Airport Road
Bangalore KARNATAKA 560017 India |
| Phone |
8948015165 |
| Fax |
|
| Email |
vidya007@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Vidyadhara Srinivasa |
| Designation |
Chairman and HOD, Spine Surgery |
| Affiliation |
Manipal Hospital, Old Airport Road, Bangalore |
| Address |
Room no. 1, Manipal Comprehensive Spine Care Centre, No. 98, Rustumbagh, Manipal Hospital, Old Airport Road
KARNATAKA 560017 India |
| Phone |
8948015165 |
| Fax |
|
| Email |
vidya007@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Vidyadhara Srinivasa |
| Designation |
Chairman and HOD, Spine Surgery |
| Affiliation |
Manipal Hospital, Old Airport Road, Bangalore |
| Address |
Room no. 1, Manipal Comprehensive Spine Care Centre, No. 98, Rustumbagh, Manipal Hospital, Old Airport Road
KARNATAKA 560017 India |
| Phone |
8948015165 |
| Fax |
|
| Email |
vidya007@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
Srinivasa Vidyadhara |
| Address |
Room no. 1, Manipal Comprehensive Spine Care Centre, No. 98, Manipal Hospital, Old Airport Road, Bangalore - 560017 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Vidyadhara Srinivasa |
Manipal Hospital |
Room no. 1, Manipal Comprehensive Spine Care Centre, No. 98, Rustam Bagh, Manipal Hospital, Old Airport Road, Bangalore - 560017, Karnataka Bangalore KARNATAKA |
9845210001
vidya007@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Ethics Committee of Manipal Hospitals |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified, (2) ICD-10 Condition: R339||Retention of urine, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Control group |
Patients of elective spine surgeries were included in this study.Foleys catheter was removed on the first post operative day and we evaluated for the incidence of post operative urinary retention. All post operative medications with regards to spine surgery remains same in both groups.In comparator group no additional medications were given for it (no silodosin used in this group). |
| Intervention |
Oral Silodosin |
Single dose of oral silodosin (8mg) is given 8 hours after surgery followed by another dose given 4 hours before the voiding trial (removal of foleys catheter), which was done on postoperative day 1.
The control group patients were not given any medications for the urinary retention. However, rest all the medications and preoperative protocols were same for both the groups.
POUR in was defined as inability to void urine after catheter removal with post void residue of more than 200 ml and needing recatheterisation. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
All patients above 18 years of age planned for spine surgery under general anaesthesia were included in the study. |
|
| ExclusionCriteria |
| Details |
Patients with neurological deficits, intra-operative dural tear, neurogenic bladder, cauda equina syndrome or conus medullaris syndrome who need indwelling catheter for a longer duration;
Patients who are non-ambulatory and need indwelling catheter for longer duration of time.
History of urinary retention requiring continuous or intermittent catheterization;
Confirmed or suspected urethral stricture, history of prostatic or bladder neck surgery or cases of prostate cancer;
History of unstable angina or myocardial infarction or cerebrovascular accidents with residual disease;
History of syncope or orthostatic hypotension;
An active prescription for an alpha receptor antagonist medication;
Impaired renal function serum creatinine more than 1.4 mg/dL or eGFR less than 90 mg/mmol;
Chronic Liver disease;
Patients taking drugs that is known to have interaction with Silodosin - Clarithromycin, Anti-retroviral drugs, Ketoconazole/Itraconazole;
Known allergy to Silodosin;
Patients unwilling or unable to give consent |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
On-site computer system |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Primary outcome is the Incidence of Post operative urinary retention (POUR) in the post operative period after removal of Foleys catheter. |
24 hours |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Length of stay, Complications, Readmission |
30 days |
|
|
Target Sample Size
|
Total Sample Size="200" Sample Size from India="200"
Final Enrollment numbers achieved (Total)= "151"
Final Enrollment numbers achieved (India)="151" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
01/11/2025 |
| Date of Study Completion (India) |
31/01/2026 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="4" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Post operative urinary retention (POUR) is a frequently encountered post operative event with an incidence ranging from 10%-20% in Orthopaedic surgeries. The rates of POUR has been reported even higher in spine surgeries due to the use of general anesthesia, longer duration of surgery, surgeries involving the lower lumbar levels and old age. With this background we hypothesised that the use of oral silodosin (superselective alpha 1 blocker) can decrease the rate of POUR in patients undergoing spine surgeries. Hypothesis - The use of super-selective alpha agonist like silodosin in the peri-operative period will reduce the incidence of post operative urinary retention in spine surgeries. Patients will be randomly allocated into two groups - Interventional group (Group 1) - Tab Silodosin 8mg will be given 8 hours after surgery followed by another dose given 4 hours before the trial voiding. Urinary catheter will be removed on the 1st post operative day. Control group (Group 2) - No additional medication shall be given for urinary retention. However, rest all the medications and protocols will remain the same. Primary Outcomes assessed - Incidence of Post operative urinary retention Benefits - To provide quality high evidence and improve post operative care in line with concept of ERAS (Early recovery after surgery) and help in preparing a guideline for patients undergoing day care surgery or being discharged early with reduced risk of POUR. |